[go: up one dir, main page]

WO2007014338A3 - Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease - Google Patents

Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease Download PDF

Info

Publication number
WO2007014338A3
WO2007014338A3 PCT/US2006/029449 US2006029449W WO2007014338A3 WO 2007014338 A3 WO2007014338 A3 WO 2007014338A3 US 2006029449 W US2006029449 W US 2006029449W WO 2007014338 A3 WO2007014338 A3 WO 2007014338A3
Authority
WO
WIPO (PCT)
Prior art keywords
cardiovascular disease
methods
susceptibility
single nucleotide
nucleotide polymorphisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/029449
Other languages
French (fr)
Other versions
WO2007014338A8 (en
WO2007014338A2 (en
Inventor
Monika Stoll
Gerd Assmann
Helmut Schulte
Werner Kroll
Stephen Schwers
Christoph Petry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Siemens Medical Solutions Diagnostics Inc USA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Medical Solutions Diagnostics Inc USA filed Critical Siemens Medical Solutions Diagnostics Inc USA
Priority to EP06788815A priority Critical patent/EP1907589A4/en
Publication of WO2007014338A2 publication Critical patent/WO2007014338A2/en
Publication of WO2007014338A8 publication Critical patent/WO2007014338A8/en
Priority to US12/019,651 priority patent/US20080233582A1/en
Anticipated expiration legal-status Critical
Publication of WO2007014338A3 publication Critical patent/WO2007014338A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention provides SNPs, polymorphic variants, and haplotypes associated with cardiovascular disease. The invention also provides methods for detecting the SNPs, polymorphic variants, and haplotypes. The invention also provides methods for determining an individual's genotype with respect to one or more polymorphisms and/or haplotypes associated with cardiovascular disease. The invention further provides methods of determining whether an individual has or is susceptible to development or occurrence of a cardiovascular disease or event. The methods are useful for providing diagnostic and/or prognostic information, selecting therapeutic regimens, etc. The invention further provides reagents and kits for practicing the methods.
PCT/US2006/029449 2005-07-26 2006-07-26 Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease Ceased WO2007014338A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP06788815A EP1907589A4 (en) 2005-07-26 2006-07-26 UNIQUE NUCLEOTIDE POLYMORPHISMS WITH SUSCEPTIBILITY IN RELATION TO CARDIOVASCULAR DISEASE
US12/019,651 US20080233582A1 (en) 2005-07-26 2008-01-25 Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US70276005P 2005-07-26 2005-07-26
US60/702,760 2005-07-26
US70321905P 2005-07-27 2005-07-27
US60/703,219 2005-07-27
US70871905P 2005-08-15 2005-08-15
US60/708,719 2005-08-15
US74240705P 2005-12-05 2005-12-05
US60/742,407 2005-12-05
EP06012722 2006-06-21
EPEP06012722.2 2006-06-21

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/019,651 Continuation-In-Part US20080233582A1 (en) 2005-07-26 2008-01-25 Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease

Publications (3)

Publication Number Publication Date
WO2007014338A2 WO2007014338A2 (en) 2007-02-01
WO2007014338A8 WO2007014338A8 (en) 2007-04-12
WO2007014338A3 true WO2007014338A3 (en) 2010-05-20

Family

ID=37683999

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/029449 Ceased WO2007014338A2 (en) 2005-07-26 2006-07-26 Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease

Country Status (2)

Country Link
EP (1) EP1907589A4 (en)
WO (1) WO2007014338A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2267153A1 (en) * 2009-05-26 2010-12-29 Université Claude Bernard Lyon 1 Identification of netrin-1 receptor unc5c gene mutation in solid cancers
AU2021239861A1 (en) * 2020-03-16 2022-10-06 The University Of North Carolina At Chapel Hill Compositions and methods for the selective detection of tumor-derived viral DNA

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113725A1 (en) * 2000-04-17 2003-06-19 Small Kersten M. Alpha-2 adrenergic receptor polymorphisms
US20040014059A1 (en) * 1999-01-06 2004-01-22 Choong-Chin Liew Method for the detection of gene transcripts in blood and uses thereof
US20050026169A1 (en) * 2002-12-20 2005-02-03 Applera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1339867A4 (en) * 1999-08-09 2005-10-12 Univ Utah Res Found CHANGES IN LONG QT SYNDROM GENES KVLQT1 AND ISCN5A AND METHOD FOR DETECTING them
AU2001241415A1 (en) * 2000-01-31 2001-08-07 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
CA2502359A1 (en) * 2002-10-17 2004-04-29 Decode Genetics Ehf. Susceptibility gene for myocardial infarction

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040014059A1 (en) * 1999-01-06 2004-01-22 Choong-Chin Liew Method for the detection of gene transcripts in blood and uses thereof
US20030113725A1 (en) * 2000-04-17 2003-06-19 Small Kersten M. Alpha-2 adrenergic receptor polymorphisms
US20050026169A1 (en) * 2002-12-20 2005-02-03 Applera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HARA ET AL.: "Identification of two cDNAs for human actin-related proteins (Arps) that have remarkable similarity to conventional actin.", BIOCHIMICA BIOPHYSICA ACTA, vol. 1522, no. 2, 2001, pages 130 - 133, XP004326977, DOI: doi:10.1016/S0167-4781(01)00315-3 *
See also references of EP1907589A4 *

Also Published As

Publication number Publication date
EP1907589A4 (en) 2010-11-24
WO2007014338A8 (en) 2007-04-12
WO2007014338A2 (en) 2007-02-01
EP1907589A2 (en) 2008-04-09

Similar Documents

Publication Publication Date Title
FI20050011A7 (en) Method and test kit for detecting the risk of type 2 diabetes mellitus
JP2012506256A5 (en)
WO2010103292A3 (en) A genotyping tool for improving the prognostic and clinical management of ms patients
WO2005082110A3 (en) Haplotype markers for diagnosing susceptibility to immunological conditions
WO2008137121A3 (en) Methods for detecting an increased risk for coronary heart disease
WO2006063704A3 (en) Single nucleotide polymorphism (snp) associated to type ii diabetes
CA2591840A1 (en) Genetic variants predicting warfarin sensitivity
WO2012079010A3 (en) Improved method and kit for determining severity and progression of periodontal disease
WO2003046203A3 (en) Genetic markers associated with desirable and undesirable traits in horses, methods of identifying and using such markers
WO2003054166A3 (en) Nucleotide polymorphisms associated with osteoarthritis
WO2006026074A3 (en) Atherosclerotic phenotype determinative genes and methods for using the same
WO2007014338A3 (en) Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease
Ide et al. Genetic and expression analyses of FZD3 in schizophrenia
CA2726078A1 (en) A combination of risk alleles associated with autism
WO2006099259A3 (en) Novel missense mutations and single nucleotide polymorphisms in the rabphillin-3a-like gene and uses thereof
WO2006028999A3 (en) Assessment of ctla-4 polymorphisms in ctla-4 blockade therapy
WO1997043446A3 (en) Diagnostic method and apparatus for detecting a predisposition to certain disease states, especially osteoporosis, based on polymorphism in an il-6 gene
Nievergelt et al. Admixture mapping as a gene discovery approach for complex human traits and diseases
WO2006053955A3 (en) Method and kit for detecting a risk of essential arterial hypertension
Kyogoku et al. Association of calcineurin A gamma subunit (PPP3CC) and early growth response 3 (EGR3) gene polymorphisms with susceptibility to schizophrenia in a Japanese population
WO2008052016A3 (en) The sortilin-related receptor sorl1 is functionally and genetically associated with alzheimer's disease
WO2008131367A3 (en) Methods of diagnosing alzheimer's disease and markers identified by set association
Lee et al. No association between AKT1 polymorphism and schizophrenia: A case–control study in a Korean population and a meta-analysis
US20140255930A1 (en) Materials and Methods Related to Dopamine Dysregulation Disorders
WO2002053018A3 (en) Method of detecting polymorphisms associated with breast carcinoma in mhc genes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006788815

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE